A new study just revealed a new drug halts progress of Alzheimer’s Disease. 

A major breakthrough in the treatment of Alzheimer’s disease is revealed today (July 29) by scientists at the Alzheimer’s Association International Conference on Alzheimer’s Disease in Chicago, Illinois.

Alzheimer’s disease is a degenerative and terminal brain disorder which affects millions of people around the world and a major and growing burden on health services in all countries with an ageing population. During the course of its progress there is a build up in the brain of lesions called plaques and tangles.

A new drug that has completed Phase II trials in the UK and Singapore is being hailed as a major breakthrough in the treatment of Alzheimer’s disease, as it appeared to slow the progress of the disease by as much as 81 percent over a year, compared to placebo. Methylthioninium chloride (MTC) blocks the accumulation of tau protein tangles inside brain cells, one of the principal characteristics of the disease.

Patients receiving the study treatment experienced an 81% reduction in cognitive decline over one year, and did not experience a significant decline in their mental function over 19 months. The TauRx brain imaging data also showed that the drug had its biggest effect in the memory critical parts of the brain where the tangle density is highest.

Please visit in a day to get more information on study revealed.

If your aging relative is living with Alzheimer’s, Home Instead Senior Care in Austin can help.  Please call us at 512-347-9207.